STATE OF WISCONSIN INVESTMENT BOARD - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 164 filers reported holding CARA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE OF WISCONSIN INVESTMENT BOARD ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$202,115
-58.9%
41,164
-10.1%
0.00%
-50.0%
Q4 2022$491,871
+19.4%
45,798
+4.1%
0.00%
+100.0%
Q3 2022$412,000
-2.6%
43,991
-5.1%
0.00%0.0%
Q2 2022$423,000
-40.7%
46,366
-21.0%
0.00%0.0%
Q1 2022$713,000
-0.3%
58,7000.0%0.00%0.0%
Q4 2021$715,000
-21.2%
58,7000.0%0.00%
-50.0%
Q3 2021$907,000
+8.2%
58,7000.0%0.00%0.0%
Q2 2021$838,000
-34.2%
58,7000.0%0.00%
-33.3%
Q1 2021$1,274,000
+43.5%
58,7000.0%0.00%
+50.0%
Q4 2020$888,000
+5.7%
58,700
-11.1%
0.00%0.0%
Q3 2020$840,000
-25.6%
66,0000.0%0.00%
-33.3%
Q2 2020$1,129,000
+39.0%
66,000
+7.3%
0.00%0.0%
Q1 2020$812,000
-1.3%
61,500
+20.4%
0.00%
+50.0%
Q4 2019$823,000
-11.9%
51,1000.0%0.00%
-33.3%
Q3 2019$934,000
-2.8%
51,100
+14.3%
0.00%0.0%
Q2 2019$961,000
+12.1%
44,700
+2.3%
0.00%
+50.0%
Q1 2019$857,000
+96.1%
43,700
+30.1%
0.00%
+100.0%
Q4 2018$437,000
-33.9%
33,600
+21.7%
0.00%
-50.0%
Q3 2018$661,000
+25.0%
27,6000.0%0.00%0.0%
Q2 2018$529,000
+113.3%
27,600
+38.0%
0.00%
+100.0%
Q1 2018$248,000
+1.2%
20,0000.0%0.00%0.0%
Q4 2017$245,000
-10.6%
20,0000.0%0.00%0.0%
Q3 2017$274,000
-11.0%
20,0000.0%0.00%0.0%
Q2 2017$308,00020,0000.00%
Other shareholders
CARA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 2,204,449$10,8241.35%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,233,000$6,054,0301.14%
Chescapmanager LLC 1,160,392$5,6980.90%
DISCIPLINED GROWTH INVESTORS INC /MN 1,732,375$8,505,9610.22%
XTX Topco Ltd 107,610$528,3650.11%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 84,530$415,0420.08%
PINNACLE ASSOCIATES LTD 679,413$3,335,9180.07%
PDT Partners, LLC 102,010$500,8690.07%
FARALLON CAPITAL MANAGEMENT LLC 1,995,370$9,797,2670.05%
AXQ CAPITAL, LP 27,760$136,3020.05%
View complete list of CARA THERAPEUTICS INC shareholders